Analyst Ratings for CRISPR Therapeutics (CRSP) [Neutrals]
CRSP Rating Summary
CRSP Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$79.07 (+47.2%)
* Over Last 12-Mos
Rating Score: 5.2 / 10 Percentile Rank: 57%
Rating Score: 5.2 / 10 Percentile Rank: 57%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/15/2024 | Wolfe Research | Andy Chen | New Coverage | Peerperform (N/A) |
N/A (N/A) |
72.78 (53.73) |
-26.17% | Details |
10/17/2023 | Cantor Fitzgerald | Olivia Brayer | Downgrade | Neutral (Buy) |
N/A (N/A) |
44.81 (53.73) |
19.91% | Details |